BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 18669910)

  • 1. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.
    Iwase T; Nagaya N; Fujii T; Itoh T; Murakami S; Matsumoto T; Kangawa K; Kitamura S
    Cardiovasc Res; 2005 Jun; 66(3):543-51. PubMed ID: 15914119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
    Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
    Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis.
    Tsuda H; Yamahara K; Ishikane S; Otani K; Nakamura A; Sawai K; Ichimaru N; Sada M; Taguchi A; Hosoda H; Tsuji M; Kawachi H; Horio M; Isaka Y; Kangawa K; Takahara S; Ikeda T
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1004-13. PubMed ID: 20739390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats.
    Ishikane S; Yamahara K; Sada M; Harada K; Kodama M; Ishibashi-Ueda H; Hayakawa K; Mishima K; Iwasaki K; Fujiwara M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2010 Nov; 49(5):753-61. PubMed ID: 20692268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia.
    Prather WR; Toren A; Meiron M; Ofir R; Tschope C; Horwitz EM
    Cytotherapy; 2009; 11(4):427-34. PubMed ID: 19526389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
    Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
    J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of acupoint injection with bone marrow mesenchymal stem cells on the blood flow in rats with hind limb ischemia].
    Zhu CJ; Dong JX; Zhang MJ; Lu GL; Li J
    Zhongguo Zhen Jiu; 2009 Dec; 29(12):987-92. PubMed ID: 20088419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.
    Wu Y; Chen L; Scott PG; Tredget EE
    Stem Cells; 2007 Oct; 25(10):2648-59. PubMed ID: 17615264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
    Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
    Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
    Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
    Poncelet AJ; Vercruysse J; Saliez A; Gianello P
    Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
    Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune properties of human umbilical cord Wharton's jelly-derived cells.
    Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
    Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
    Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
    Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.